Discrimination and identification of Q-markers based on 'Spider-web' mode for quality control of traditional Chinese medicine

被引:28
作者
Jiang, Zhenzuo [1 ,2 ]
Yang, Jing [1 ,2 ]
Wang, Yuefei [1 ,2 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 300193, Peoples R China
[2] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin 300457, Peoples R China
基金
中国国家自然科学基金;
关键词
Q-markers; 'Spider-web' mode; Quality control; Traditional Chinese medicine; FLIGHT MASS-SPECTROMETRY; SERUM PHARMACOCHEMISTRY; CHEMOMETRIC ANALYSIS; COMPONENTS; MS; CONSTITUENTS; FINGERPRINT; DECOCTION; SAPONINS; EFFICACY;
D O I
10.1016/j.phymed.2017.12.034
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: The safety and effectiveness of traditional Chinese medicine (TCM) in clinical practice is directly related to the quality of TCM. And, the quality control of TCM is a pivotal issue to the quality of TCM, but also an obstacle impeding the modernization of TCM. Purpose: The purpose of this work is to compile and develop a strategy based on discrimination and identification of quality markers (Q-markers) for quality control of TCM. Methods: Mainly established by seven variables derived from four dimensions including content, stability, pharmacokinetics and pharmacology, the 'Spider-web' mode was undertaken to assess the Q-marker property of candidate compounds originated from TCM by taking regression area (A) and coefficient variation (CV) of the tested compounds into account. The importance index (ImI), ImI = A x 1/CV, was suggested to focus Q-markers. Results: The compounds with larger regression area (A) and less coefficient variation (CV) are preferentially adopted as Q-markers, which should possess the satisfactory properties of content, stability, pharmacokinetics and pharmacological activity. To the contrary, the compounds are excluded on the grounds of the unsatisfactory Q-markers' property, less regression area (A) and larger coefficient variation (CV), which cannot represent the quality of TCM. Conclusions: The 'Spider-web' mode can filter out the redundant constituents and focus on the key indexes of quality control - Q-markers. The screened Q-markers possess the optimal integrated properties of content, stability, pharmacokinetics and pharmacology among the numerous and complicated ingredients of TCM, which can comprehensively characterize inherent quality of TCM. In summary, the novel strategy established in this work provides a valuable perspective for the quality control of TCM.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 37 条
  • [1] [Anonymous], 2003, STAB TEST NEW DRUG S
  • [2] Chinese medicinal materials and their interface with Western medical concepts
    Chan, K
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2005, 96 (1-2) : 1 - 18
  • [3] Deng WP, 2015, NAT PROD COMMUN, V10, P71
  • [4] He J.L, 2015, EVID-BASED COMPL ALT, V2015
  • [5] Jia W, 2015, SCIENCE, V350, pS76
  • [6] Ultra high performance liquid chromatography coupled with triple quadrupole mass spectrometry and chemometric analysis of licorice based on the simultaneous determination of saponins and flavonoids
    Jiang, Zhenzuo
    Wang, Yuefei
    Zheng, Yunfeng
    Yang, Jing
    Zhang, Lei
    [J]. JOURNAL OF SEPARATION SCIENCE, 2016, 39 (15) : 2928 - 2940
  • [7] Dose-dependent targeted knockout methodology combined with deep structure elucidation strategies for Chinese licorice chemical profiling
    Jiang, Zhenzuo
    Wang, Yuefei
    Zhu, Yan
    Zhang, Lei
    Chai, Xin
    Jiang, Miaomiao
    Shan, Lihua
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 115 : 130 - 137
  • [8] Screening the active compounds of Phellodendri Amurensis cortex for treating prostate cancer by high-throughput chinmedomics
    Li, Xian-Na
    Zhang, Aihua
    Wang, Meijia
    Sun, Hui
    Liu, Zhidong
    Qiu, Shi
    Zhang, Tianlei
    Wang, Xijun
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [9] A Metabolomics-Based Strategy for the Quality Control of Traditional Chinese Medicine: Shengmai Injection as a Case Study
    Li, Xiaodong
    Chen, Huiyuan
    Jia, Wei
    Xie, Guoxiang
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [10] Li YZ, 2015, CURR DRUG METAB, V16, P765